193 related articles for article (PubMed ID: 15351486)
1. Porcine adenoviral vectors evade preexisting humoral immunity to adenoviruses and efficiently infect both human and murine cells in culture.
Bangari DS; Mittal SK
Virus Res; 2004 Oct; 105(2):127-36. PubMed ID: 15351486
[TBL] [Abstract][Full Text] [Related]
2. Porcine adenovirus serotype 3 internalization is independent of CAR and alphavbeta3 or alphavbeta5 integrin.
Bangari DS; Mittal SK
Virology; 2005 Feb; 332(1):157-66. PubMed ID: 15661148
[TBL] [Abstract][Full Text] [Related]
3. Circumvention of vector-specific neutralizing antibody response by alternating use of human and non-human adenoviruses: implications in gene therapy.
Moffatt S; Hays J; HogenEsch H; Mittal SK
Virology; 2000 Jun; 272(1):159-67. PubMed ID: 10873758
[TBL] [Abstract][Full Text] [Related]
4. Comparative transduction efficiencies of human and nonhuman adenoviral vectors in human, murine, bovine, and porcine cells in culture.
Bangari DS; Shukla S; Mittal SK
Biochem Biophys Res Commun; 2005 Feb; 327(3):960-6. PubMed ID: 15649439
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses.
Sharma A; Tandon M; Ahi YS; Bangari DS; Vemulapalli R; Mittal SK
Gene Ther; 2010 May; 17(5):634-42. PubMed ID: 20164856
[TBL] [Abstract][Full Text] [Related]
6. PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver.
Croyle MA; Chirmule N; Zhang Y; Wilson JM
Hum Gene Ther; 2002 Oct; 13(15):1887-900. PubMed ID: 12396620
[TBL] [Abstract][Full Text] [Related]
7. Persistence and the state of bovine and porcine adenoviral vector genomes in human and nonhuman cell lines.
Sharma A; Bangari DS; Vemula SV; Mittal SK
Virus Res; 2011 Nov; 161(2):181-7. PubMed ID: 21864589
[TBL] [Abstract][Full Text] [Related]
8. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.
Imler JL; Chartier C; Dreyer D; Dieterle A; Sainte-Marie M; Faure T; Pavirani A; Mehtali M
Gene Ther; 1996 Jan; 3(1):75-84. PubMed ID: 8929914
[TBL] [Abstract][Full Text] [Related]
9. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T; Mizuguchi H
Gene Ther; 2005 Oct; 12(19):1424-33. PubMed ID: 15944730
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model.
Sharma A; Bangari DS; Tandon M; Pandey A; HogenEsch H; Mittal SK
Virology; 2009 Mar; 386(1):44-54. PubMed ID: 19211122
[TBL] [Abstract][Full Text] [Related]
11. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
[TBL] [Abstract][Full Text] [Related]
12. A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions.
Wang Q; Jia XC; Finer MH
Gene Ther; 1995 Dec; 2(10):775-83. PubMed ID: 8750018
[TBL] [Abstract][Full Text] [Related]
13. Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.
Holterman L; Vogels R; van der Vlugt R; Sieuwerts M; Grimbergen J; Kaspers J; Geelen E; van der Helm E; Lemckert A; Gillissen G; Verhaagh S; Custers J; Zuijdgeest D; Berkhout B; Bakker M; Quax P; Goudsmit J; Havenga M
J Virol; 2004 Dec; 78(23):13207-15. PubMed ID: 15542673
[TBL] [Abstract][Full Text] [Related]
14. Induction of systemic and mucosal immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD.
Mittal SK; Papp Z; Tikoo SK; Baca-Estrada ME; Yoo D; Benko M; Babiuk LA
Virology; 1996 Aug; 222(2):299-309. PubMed ID: 8806514
[TBL] [Abstract][Full Text] [Related]
15. Novel recombinant adenovirus type 41 vector and its biological properties.
Lu ZZ; Zou XH; Dong LX; Qu JG; Song JD; Wang M; Guo L; Hung T
J Gene Med; 2009 Feb; 11(2):128-38. PubMed ID: 19097028
[TBL] [Abstract][Full Text] [Related]
16. Efficient gene transfer into normal human B lymphocytes with the chimeric adenoviral vector Ad5/F35.
Jung D; Néron S; Drouin M; Jacques A
J Immunol Methods; 2005 Sep; 304(1-2):78-87. PubMed ID: 16129448
[TBL] [Abstract][Full Text] [Related]
17. Fiber-modified adenovirus vectors containing the TAT peptide derived from HIV-1 in the fiber knob have efficient gene transfer activity.
Kurachi S; Tashiro K; Sakurai F; Sakurai H; Kawabata K; Yayama K; Okamoto H; Nakagawa S; Mizuguchi H
Gene Ther; 2007 Aug; 14(15):1160-5. PubMed ID: 17508008
[TBL] [Abstract][Full Text] [Related]
18. Human adenovirus type 35: nucleotide sequence and vector development.
Gao W; Robbins PD; Gambotto A
Gene Ther; 2003 Nov; 10(23):1941-9. PubMed ID: 14528318
[TBL] [Abstract][Full Text] [Related]
19. A recombinant E1-deleted porcine adenovirus-3 as an expression vector.
Zakhartchouk A; Zhou Y; Tikoo SK
Virology; 2003 Sep; 313(2):377-86. PubMed ID: 12954206
[TBL] [Abstract][Full Text] [Related]
20. Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species.
Jogler C; Hoffmann D; Theegarten D; Grunwald T; Uberla K; Wildner O
J Virol; 2006 Apr; 80(7):3549-58. PubMed ID: 16537623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
